Pierre van der Bruggen

Person

Brussels, BE

People

Patents Grantslast 30 patents

Information Patent Grant
Method for modulating activity of T lymphocytes
- Patent number 8,951,747
- Issue date Feb 10, 2015
- Ludwig Institute for Cancer Research
- Nathalie Demotte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Detection of individual T-cell reaction patterns against tumor-asso...
- Patent number 8,349,558
- Issue date Jan 8, 2013
- Johannes Gutenberg-Universität Mainz
- Martina Fatho
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immunogenic polypeptides encoded by MAGE minigenes and uses thereof
- Patent number 8,257,717
- Issue date Sep 4, 2012
- Sanofi Pasteur Limited
- Neil Berinstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3
- Patent number 7,923,534
- Issue date Apr 12, 2011
- Ludwig Institute for Cancer Research
- Thierry Boon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunogenic polypeptides encoded by MAGE minigenes and uses thereof
- Patent number 7,851,212
- Issue date Dec 14, 2010
- Sanofi Pasteur Limited
- Neil Berinstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated peptide which binds to HLA-Cw*07 and uses thereof
- Patent number 7,488,793
- Issue date Feb 10, 2009
- Ludwig Institute for Cancer Research
- Pierre Van Der Bruggen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MAGE peptides presented by HLA class II molecules
- Patent number 7,388,072
- Issue date Jun 17, 2008
- Ludwig Institute for Cancer Research
- Yi Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tumor antigens and CTL clones isolated by a novel procedure
- Patent number 7,351,409
- Issue date Apr 1, 2008
- Ludwig Institute for Cancer Research
- Pascal Chaux
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen...
- Patent number RE40089
- Issue date Feb 19, 2008
- Ludwig Institute for Cancer Research
- Thierry Boon-Falleur
- 536 - Organic compounds
Information Patent Grant
MAGE-A4 antigenic peptides and uses thereof
- Patent number 7,311,914
- Issue date Dec 25, 2007
- Ludwig Institute for Cancer Research
- Yi Zhang
- G01 - MEASURING TESTING
Information Patent Grant
MAGE-3 peptides presented by HLA class II molecules
- Patent number 7,252,825
- Issue date Aug 7, 2007
- Ludwig Institute for Cancer Research
- Pascal Chaux
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated nucleic acid molecules coding for tumor rejection antigen...
- Patent number 7,199,231
- Issue date Apr 3, 2007
- Ludwig Institute for Cancer Research
- Béatrice Guagler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MAGE-A1 peptides presented by HLA class II molecules
- Patent number 7,157,091
- Issue date Jan 2, 2007
- Ludwig Institute for Cancer Research
- Jacques Van Snick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MAGE-A3 peptides presented by HLA class II molecules
- Patent number 7,049,413
- Issue date May 23, 2006
- Ludwig Institute for Cancer Research
- Yi Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated peptides which bind to HLA-B18 molecules and uses thereof
- Patent number 7,041,502
- Issue date May 9, 2006
- Ludwig Institute for Cancer Research
- Janine Bilsborough
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated nucleic acid molecules coding for tumor rejection antigen...
- Patent number 6,946,289
- Issue date Sep 20, 2005
- Ludwig Institute for Cancer Research
- Béatrice Guagler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated nucleic acid molecules which encode GAGE genes and uses th...
- Patent number 6,939,707
- Issue date Sep 6, 2005
- Ludwig Institute for Cancer Research
- Pierre van der Bruggen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tumor antigens and CTL clones isolated by a novel procedure
- Patent number 6,710,172
- Issue date Mar 23, 2004
- Ludwig Institute for Cancer Research
- Pascal Chaux
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isolated peptides derived from mage tumor rejection antigen precurs...
- Patent number 6,682,731
- Issue date Jan 27, 2004
- Ludwig Institute for Cancer Research
- Alan Townsend
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
METHOD FOR IDENTIFYING INDIVIDUALS SUFFERING FROM A CELLULAR ABNORM...
- Patent number 6,680,056
- Issue date Jan 20, 2004
- Ludwig Institute for Cancer Research
- Pierre van der Bruggen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for treating subjects by using BAGE tumor rejection antigen...
- Patent number 6,638,512
- Issue date Oct 28, 2003
- Ludwig Institute for Cancer Research
- Pascale Boel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Delivery of proteins into eukaryotic cells with recombinant Yersinia
- Patent number 6,602,506
- Issue date Aug 5, 2003
- Ludwig Institute for Cancer Research
- Pierre B. van der Bruggen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Tumor antigens and CTL clones isolated by a novel procedure
- Patent number 6,531,451
- Issue date Mar 11, 2003
- Ludwig Institute for Cancer Research
- Pascal Chaux
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for treating cancer by administering MAGE-derived peptides
- Patent number 6,488,932
- Issue date Dec 3, 2002
- Ludwig Institute for Cancer Research
- Thierry Boon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated nucleic acid molecule encoding peptides which form complex...
- Patent number 6,465,184
- Issue date Oct 15, 2002
- Ludwig Institute for Cancer Research
- Pascale Boel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated molecules which complex with HLA-Cw*16 molecules, and uses...
- Patent number 6,429,287
- Issue date Aug 6, 2002
- Ludwig Institute for Cancer Research
- Pierre van der Bruggen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MAGE-3 peptides presented by HLA class II molecules
- Patent number 6,426,217
- Issue date Jul 30, 2002
- Ludwig Institute for Cancer Research
- Pascal Chaux
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for screening for cancer using binders for MAGE related pept...
- Patent number 6,379,901
- Issue date Apr 30, 2002
- Ludwig Institute for Cancer Research
- Thierry Boon-Falleur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MAGE-3 peptides presented by HLA class II molecules
- Patent number 6,369,211
- Issue date Apr 9, 2002
- Ludwig Institute for Cancer Research
- Pascal Chaux
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for stimulating CTLs with peptides
- Patent number 6,353,089
- Issue date Mar 5, 2002
- Ludwig Institute for Cancer Research
- Pierre van der Bruggen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Melanoma-Associated MHC Class I Associated Oligopeptides and the Us...
- Publication number 20150366957
- Publication date Dec 24, 2015
- Johannes Gutenberg-Universitat Mainz
- Daniela EBERTS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Immunogenic Polypeptides Encoded by MAGE Minigenes and Uses Thereof
- Publication number 20130216563
- Publication date Aug 22, 2013
- Neil Berinstein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD FOR MODULATING ACTIVITY OF T LYMPHOCYTES
- Publication number 20120196363
- Publication date Aug 2, 2012
- Ludwig Institute for Cancer Research
- Nathalie DEMOTTE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Immunogenic Polypeptides Encoded by MAGE Minigenes and Uses Thereof
- Publication number 20110250234
- Publication date Oct 13, 2011
- Neil Berinstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Detection of Individual T-Cell Reaction Patterns Against Tumor-Asso...
- Publication number 20100035267
- Publication date Feb 11, 2010
- Martina Fatho
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MAGE-A3 PEPTIDES PRESENTED BY HLA-DR1 MOLECULES
- Publication number 20090203124
- Publication date Aug 13, 2009
- Ludwig Institute for Cancer Research
- Yi Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Melanoma-associated MHC class I associated oligopeptides and the us...
- Publication number 20090104186
- Publication date Apr 23, 2009
- Daniela Eberts
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Isolated peptides which bind to HLA-A24 molecules and uses thereof
- Publication number 20050249743
- Publication date Nov 10, 2005
- Thierry Boon-Falleur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MAGE peptides presented by HLA class II molecules
- Publication number 20040077045
- Publication date Apr 22, 2004
- Yi Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Immunogenic polypetides encoded by mage minigenes and uses thereof
- Publication number 20040033234
- Publication date Feb 19, 2004
- Neil Berinstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Pierre van der Bruggen

Person

Patents Grantslast 30 patents

Method for modulating activity of T lymphocytes

Detection of individual T-cell reaction patterns against tumor-asso...

Immunogenic polypeptides encoded by MAGE minigenes and uses thereof

Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3

Immunogenic polypeptides encoded by MAGE minigenes and uses thereof

Isolated peptide which binds to HLA-Cw*07 and uses thereof

MAGE peptides presented by HLA class II molecules

Tumor antigens and CTL clones isolated by a novel procedure

Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen...

MAGE-A4 antigenic peptides and uses thereof

MAGE-3 peptides presented by HLA class II molecules

Isolated nucleic acid molecules coding for tumor rejection antigen...

MAGE-A1 peptides presented by HLA class II molecules

MAGE-A3 peptides presented by HLA class II molecules

Isolated peptides which bind to HLA-B18 molecules and uses thereof

Isolated nucleic acid molecules coding for tumor rejection antigen...

Isolated nucleic acid molecules which encode GAGE genes and uses th...

Tumor antigens and CTL clones isolated by a novel procedure

Isolated peptides derived from mage tumor rejection antigen precurs...

METHOD FOR IDENTIFYING INDIVIDUALS SUFFERING FROM A CELLULAR ABNORM...

Method for treating subjects by using BAGE tumor rejection antigen...

Delivery of proteins into eukaryotic cells with recombinant Yersinia

Tumor antigens and CTL clones isolated by a novel procedure

Method for treating cancer by administering MAGE-derived peptides

Isolated nucleic acid molecule encoding peptides which form complex...

Isolated molecules which complex with HLA-Cw*16 molecules, and uses...

MAGE-3 peptides presented by HLA class II molecules

Method for screening for cancer using binders for MAGE related pept...

MAGE-3 peptides presented by HLA class II molecules

Method for stimulating CTLs with peptides

Patents Applicationslast 30 patents

Melanoma-Associated MHC Class I Associated Oligopeptides and the Us...

Immunogenic Polypeptides Encoded by MAGE Minigenes and Uses Thereof

METHOD FOR MODULATING ACTIVITY OF T LYMPHOCYTES

Immunogenic Polypeptides Encoded by MAGE Minigenes and Uses Thereof

Detection of Individual T-Cell Reaction Patterns Against Tumor-Asso...

MAGE-A3 PEPTIDES PRESENTED BY HLA-DR1 MOLECULES

Melanoma-associated MHC class I associated oligopeptides and the us...

Isolated peptides which bind to HLA-A24 molecules and uses thereof

MAGE peptides presented by HLA class II molecules

Immunogenic polypetides encoded by mage minigenes and uses thereof